...
首页> 外文期刊>Biopharmaceutics & Drug Disposition >Tumor necrosis factor alpha increases P-glycoprotein expression in a BME-UV in vitro model of mammary epithelial cells
【24h】

Tumor necrosis factor alpha increases P-glycoprotein expression in a BME-UV in vitro model of mammary epithelial cells

机译:在乳腺上皮细胞体外模型中,肿瘤坏死因子α增加P-糖蛋白表达

获取原文
获取原文并翻译 | 示例
           

摘要

P-glycoprotein is an efflux pump belonging to the ATP-binding cassette super-family that influences the bioavailability and disposition of many drugs. Mammary epithelial cells express various drug transporters including P-glycoprotein, albeit at low level during lactation. During inflammatory reactions, which can be associated with changes in epithelial barrier functions, pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-) are elevated in milk and serum. In this study, the role of TNF- in the regulation of P-glycoprotein was determined in cultured BME-UV cells, an immortalized bovine mammary epithelial cell line. The protein production of P-glycoprotein and mRNA expression of bABCB1, the gene encoding P-glycoprotein, were increased after 24 h of TNF- exposure. The highest observed effects for TNF- on the regulation of P-glycoprotein was after 72 h of exposure. Protein and mRNA expression also increased significantly after 120 h of TNF- exposure, but was lower than the level observed in the cells exposed to TNF- for 72 h. The apical to basolateral flux of digoxin, a P-glycoprotein substrate, was decreased in the TNF--exposed epithelium. This effect was reversed when verapamil or ketoconazole, compounds known to interact with P-glycoprotein, were added together with digoxin into the donor compartment. Probenecid, a compound known to interact with organic anion transporters, but not P-glycoprotein, did not increase the flux of digoxin. This model has important implications for understanding the barrier function of the mammary epithelium and provides insight into the role of P-glycoprotein in the accumulation and/or removal of xenobiotics from milk and/or plasma. Copyright © 2010 John Wiley & Sons, Ltd.
机译:P-糖蛋白是属于ATP结合盒超家族的外排泵,会影响许多药物的生物利用度和处置。乳腺上皮细胞表达各种药物转运蛋白,包括P-糖蛋白,尽管在泌乳期水平较低。在可能与上皮屏障功能改变有关的炎症反应过程中,乳和血清中的促炎细胞因子(例如肿瘤坏死因子α(TNF-))升高。在这项研究中,在培养的BME-UV细胞(一种永生化的牛乳腺上皮细胞系)中确定了TNF-在调节P-糖蛋白中的作用。暴露于TNF 24小时后,P糖蛋白的蛋白产量和编码P糖蛋白的基因bABCB1的mRNA表达增加。 TNF-α对P-糖蛋白调节的最大影响是在暴露72h后。 TNF-暴露120µh后,蛋白质和mRNA表达也显着增加,但低于TNF-暴露72µh的细胞中观察到的水平。在暴露于TNF的上皮中,地高辛(一种P-糖蛋白的底物)的根尖至基底外侧通量减少。当将维拉帕米或酮康唑(已知与P-糖蛋白相互作用的化合物)与地高辛一起加入供体区室时,这种作用被逆转。丙磺舒是已知与有机阴离子转运蛋白相互作用的化合物,但与P-糖蛋白没有相互作用,但并未增加地高辛的通量。该模型对于理解乳腺上皮的屏障功能具有重要意义,并提供了对P糖蛋白在从牛奶和/或血浆中积累和/或去除异种生物中的作用的见解。版权所有©2010 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号